FR805M - - Google Patents

Info

Publication number
FR805M
FR805M FR831847A FR831847A FR805M FR 805 M FR805 M FR 805M FR 831847 A FR831847 A FR 831847A FR 831847 A FR831847 A FR 831847A FR 805 M FR805 M FR 805M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR831847A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR831847A priority Critical patent/FR805M/fr
Priority to GB1748061A priority patent/GB929252A/en
Priority to BE604839A priority patent/BE604839A/fr
Priority to CH697061A priority patent/CH406224A/fr
Priority to ES0268523A priority patent/ES268523A1/es
Priority to DE19611445138 priority patent/DE1445138C/de
Application granted granted Critical
Publication of FR805M publication Critical patent/FR805M/fr
Priority to FR881057A priority patent/FR32F/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FR831847A 1960-06-30 1960-06-30 Expired FR805M (uk)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR831847A FR805M (uk) 1960-06-30 1960-06-30
GB1748061A GB929252A (en) 1960-06-30 1961-06-02 New 1-(trialkoxy benzyl)-piperazines
BE604839A BE604839A (fr) 1960-06-30 1961-06-09 Nouvelles substances vaso-dilatatrices.
CH697061A CH406224A (fr) 1960-06-30 1961-06-14 Procédé de préparation de dérivés trialcoxylés de la benzyl-1-pipérazine
ES0268523A ES268523A1 (es) 1960-06-30 1961-06-22 Procedimiento de preparaciën de los derivados trialcoxilados de la bencil-1-piperacina
DE19611445138 DE1445138C (de) 1960-06-30 1961-06-30 Verfahren zur Herstellung von l-(2,3,4-Trimethoxybenzyi)-piperazin und Säureadditionssalzen davon
FR881057A FR32F (fr) 1960-06-30 1961-12-05 Nouvelle substance vasodilatatrice.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR831847A FR805M (uk) 1960-06-30 1960-06-30

Publications (1)

Publication Number Publication Date
FR805M true FR805M (uk) 1961-09-01

Family

ID=8734718

Family Applications (1)

Application Number Title Priority Date Filing Date
FR831847A Expired FR805M (uk) 1960-06-30 1960-06-30

Country Status (5)

Country Link
BE (1) BE604839A (uk)
CH (1) CH406224A (uk)
ES (1) ES268523A1 (uk)
FR (1) FR805M (uk)
GB (1) GB929252A (uk)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490963A1 (fr) * 1980-09-30 1982-04-02 Science Union & Cie Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine
EP0453365A1 (fr) * 1990-04-20 1991-10-23 Adir Et Compagnie Procédé de préparation de la 1-(2,3,4-triméthoxybenzyl) pipérazine par amination réductive
EP0617027A1 (fr) * 1993-03-24 1994-09-28 Adir Et Compagnie Nouveaux composés de N-benzylpipérazine leur procédé de préparation et les compositions pharmaceutiques les renfermant
FR2723944A1 (fr) * 1994-08-25 1996-03-01 Adir Nouveaux sels de trimetazidine et leur utilisation en therapeutique
EP0847999A1 (fr) * 1996-12-16 1998-06-17 Adir Et Compagnie Dérivés de N-benzylpipérazine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2805463A1 (fr) * 2000-02-25 2001-08-31 Adir UTILISATION DE LA TRIMETAZIDINE POUR L'OBTENTION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES A INHIBER L'ACYL-CoA ACETYLTRANSFERASE

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61161272A (ja) * 1985-01-11 1986-07-21 Kanebo Ltd 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物
EP1195160B1 (en) * 2000-10-05 2009-09-16 USV Ltd. Sustained release trimetazidine pharmaceutical compositions and a method of their preparation
CN100413854C (zh) * 2004-06-29 2008-08-27 北京德众万全药物技术开发有限公司 一种曲美他嗪及其药用盐的制备方法
WO2024218267A2 (en) 2023-04-20 2024-10-24 Les Laboratoires Servier Novel trimetazidine solid phases

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490963A1 (fr) * 1980-09-30 1982-04-02 Science Union & Cie Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine
EP0453365A1 (fr) * 1990-04-20 1991-10-23 Adir Et Compagnie Procédé de préparation de la 1-(2,3,4-triméthoxybenzyl) pipérazine par amination réductive
FR2661176A1 (fr) * 1990-04-20 1991-10-25 Adir Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive.
US5142053A (en) * 1990-04-20 1992-08-25 Adir Et Compagnie Process for the preparation of 1-(2,3,4-trimethoxybenzyl)piperazine by reductive animation
EP0617027A1 (fr) * 1993-03-24 1994-09-28 Adir Et Compagnie Nouveaux composés de N-benzylpipérazine leur procédé de préparation et les compositions pharmaceutiques les renfermant
FR2703048A1 (fr) * 1993-03-24 1994-09-30 Adir Nouveaux composés N-Benzylpiperazine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
FR2723944A1 (fr) * 1994-08-25 1996-03-01 Adir Nouveaux sels de trimetazidine et leur utilisation en therapeutique
EP0847999A1 (fr) * 1996-12-16 1998-06-17 Adir Et Compagnie Dérivés de N-benzylpipérazine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2757164A1 (fr) * 1996-12-16 1998-06-19 Adir Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2805463A1 (fr) * 2000-02-25 2001-08-31 Adir UTILISATION DE LA TRIMETAZIDINE POUR L'OBTENTION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES A INHIBER L'ACYL-CoA ACETYLTRANSFERASE
WO2001064220A1 (fr) * 2000-02-25 2001-09-07 Les Laboratoires Servier UTILISATION DE TRIMETAZIDINE POUR INHIBER L'ACYL-CoA ACETYLTRANSFERASE

Also Published As

Publication number Publication date
CH406224A (fr) 1966-01-31
GB929252A (en) 1963-06-19
BE604839A (fr) 1961-10-02
DE1445138A1 (de) 1969-02-20
ES268523A1 (es) 1961-10-16

Similar Documents

Publication Publication Date Title
FR805M (uk)
DE1230001C2 (uk)
DK101732A (uk)
IT649680A (uk)
FI40521B (uk)
FR708M (uk)
FR685M (uk)
FR1561902A (uk)
FR1286464A (uk)
BE610298A (uk)
BE608605A (uk)
CH698160A4 (uk)
CH1489561A4 (uk)
BE642486A (uk)
BE609485A (uk)
BE606513A (uk)
BE605404A (uk)
BE605226A (uk)
BE589930A (uk)
BE611989A (uk)
BE611983A (uk)
BE611246A (uk)
BE611163A (uk)
BE610896A (uk)
BE599887A (uk)